Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
documented a novel suppressor of ferroptosis-ferroptosis suppressor protein 1 (FSP1)
Management of hypertensive disorders during pregnancy: summary of NICE guidance
Using MDS-UPDRS part III scores in the ON-condition at month 12 as primary outcome the trial found a statistically significant difference in favour of lixisenatide of 3 score points, but there was no significant difference on any of the secondary efficacy outcomes including MDS-UPDRS part II scores
Involvement of nuclear factor-1 (NF1) binding motif in the regucalcin gene expression of rat kidney cortex: The expression is suppressed by cisplatin administration
US$ 25.04
US$ 22.64
US$ 20.66
US$ 22.76
US$ 24.59
US$ 21.58
US$ 27.98
US$ 24.10
